Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
US7053104B2 · kind B2 · utility
7Cited by
4References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2002 |
| Grant date | May 30, 2006 |
| Priority date | — |
| Expiry date | Dec 5, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.